TAIPEI, Jan 30 (Reuters) - Taiwan completed the maiden underwater sea trial for its first domestically developed submarine on Thursday, a big milestone in a project aimed at strengthening deterrence
The Union Solidarity and Development Party (USDP), backed by Myanmar's military, has secured a commanding majority in the country's protracted general election, a result widely anticipated but condemned by critics as a sham designed to cement junta control.
Russian forces are integrating Starlink satellite terminals into their drone fleet, creating a new generation of long-range, jamming-resistant weapons capable of striking deep behind Ukrainian lines and into NATO territory, according to intelligence reports and military analysts.
Eagle Materials Inc. (NYSE:EXP) boasts a Return on Equity nearly double the industry average. But as investors cheer the metric, a deeper look reveals a heavy reliance on debt, raising questions about the sustainability of its impressive performance.
German American Bancorp (NASDAQ:GABC) announces a dividend increase to $0.31 per share, reflecting confidence in its earnings trajectory and commitment to shareholder returns amidst a stable banking outlook.
A deep dive into Kadant Inc.'s intrinsic value using a Discounted Cash Flow model suggests the stock is trading near its estimated fair value of $273, raising questions about its near-term upside potential amid current market prices.
While Virco Mfg. Corporation's stock has declined nearly 10% over the past quarter, a deeper look at its financials—particularly its high profit reinvestment and strong earnings growth—suggests underlying strength that the market may be overlooking.
Multiple executives and board members at AmeriServ Financial have been buying shares in the company over the past year, a move often interpreted as a bullish signal for the regional bank's prospects.
Northwest Bancshares (NASDAQ: NWBI) confirms a $0.20 per share dividend payment in February, maintaining its long-standing shareholder returns despite a high payout ratio that raises some sustainability questions.
Amidst a backdrop of market uncertainty, investors are turning their attention to resilient companies with strong fundamentals. We spotlight three lesser-known European firms—from construction tech to cybersecurity and fashion retail—that are demonstrating robust growth and strategic positioning for the year ahead.
Amidst market turbulence, European investors are turning to high-yield dividend stocks for income stability. We examine three companies offering compelling payouts, weighing their potential rewards against inherent risks.
Shares of life sciences toolmaker Qiagen (NYSE:QGEN) have shown renewed momentum, gaining over 12% in the past month. This surge brings the company's valuation into sharp focus, with analysts divided between near-term earnings multiples and long-term cash flow projections.
Multiple company directors at the UK hydrogen power specialist have invested heavily in its stock over the past year, a move often interpreted as a bullish signal on future prospects, despite the shares trading significantly higher now.
Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.
Amid a broad crypto market downturn, Bitcoin's relative resilience and long-term growth narrative make it a standout choice for investors looking to deploy a modest $500, despite the allure of riskier, high-volatility alternatives.
Nomura Holdings (TSE:9716) has surged 33% in three months, briefly pausing last week. As shares hover around ¥1,367, analysts debate whether the market has fully priced in the brokerage's recovery or if a significant valuation gap remains.
Baker Hughes (BKR) is accelerating its pivot beyond traditional oil and gas, securing key roles in a landmark U.S. clean ammonia plant and expanding its stake in long-duration energy storage technology through a deepened partnership with Hydrostor.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Northeast Bank's Q2 2026 results reveal a bank in transition: record loan growth and a promising new small business product are countered by rising charge-offs and a token dividend, leaving analysts divided on its investment narrative.
Wall Street analysts have issued a dramatic upgrade to revenue projections for Americas Gold and Silver Corp., forecasting a surge to $383 million by 2026 and signaling accelerated growth far beyond industry peers.
